Bharat

'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech

Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog

'Panchnama' of politics being done on vaccine | Bharat Ki Baat | 2 July 2021

Coronavirus HIGHLIGHTS: Confident Of Getting EMA's Approval In A month For Covishield, Says SII Chief Adar Poonawalla

Know truth behind conversion of Sikh girl | Bharat Ki Baat(30.06.2021)

Covaxin Effectively Neutralises Covid-19's Alpha & Delta Variant: US Health Research Institute

'Pricing Clearly Established For Supplies Outside India': Bharat Biotech On Brazil Covaxin Deal Controversy

Brazil To Suspend USD 324 Million Covaxin Vaccine Deal Over Accusations Of Irregularities

Sikh community seek action against conversion of 2 girls in Kashmir | Bharat Ki Baat(29.06.2021)

Indians leading in the race of vaccination? | Bharat Ki Baat(28.06.2021)

Brazil Govt Faces Probe For Choosing Bharat Biotech's Covaxin Deal Over 'Cheaper' Pfizer Vaccine | All About Controversy

'Postmortem' of political uproar over SC panel report on Oxygen demand in Delhi | Bharat Ki Baat | 25 June 2021